Search Results

Linking Human Betaretrovirus with Autoimmunity and Liver Disease in Patients with Primary Biliary Cholangitis.

• Authors : Syed H; Department of Medicine, University of Alberta, Edmonton, AB T6G 2E1, Canada.; Center of Excellence for Gastrointestinal Inflammation and Immunity Research, University of Alberta, Edmonton, AB T6G 2E1, Canada.

Subjects: Betaretrovirus* ; Liver Cirrhosis, Biliary*/Liver Cirrhosis, Biliary*/Liver Cirrhosis, Biliary*/drug therapy ; Liver Cirrhosis, Biliary*/Liver Cirrhosis, Biliary*/Liver Cirrhosis, Biliary*/pathology

• Source: Viruses [Viruses] 2022 Aug 31; Vol. 14 (9). Date of Electronic Publication: 2022 Aug 31.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

Record details

Frequent proviral integration of the human betaretrovirus in biliary epithelium of patients with autoimmune and idiopathic liver disease.

• Authors : Wang, W.; Indik, S.; Wasilenko, S. T.

Subjects: EPITHELIUM; LIVER diseases; EPITHELIAL cells

• Source: Alimentary Pharmacology & Therapeutics. Feb2015, Vol. 41 Issue 4, p393-405. 13p.

Record details

Agricola

Record details

The intestinal and biliary microbiome in autoimmune liver disease-current evidence and concepts.

• Authors : Liwinski T; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany. .; Heinemann M

Subjects: Autoimmune Diseases*/Autoimmune Diseases*/Autoimmune Diseases*/etiology ; Autoimmune Diseases*/Autoimmune Diseases*/Autoimmune Diseases*/metabolism ; Hepatitis, Autoimmune*/Hepatitis, Autoimmune*/Hepatitis, Autoimmune*/etiology

• Source: Seminars in immunopathology [Semin Immunopathol] 2022 Jul; Vol. 44 (4), pp. 485-507. Date of Electronic Publication: 2022 May 10.Publisher: Springer Country of Publication: Germany NLM ID: 101308769 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1863-2300

Record details

Animal models of primary biliary cholangitis: status and challenges.

• Authors : Wang, Xu; Wei, Yi; Yang, Yanlei

Subjects: ANIMAL models in research; CHOLANGITIS; DRUG target

• Source: Cell & Bioscience; 11/22/2023, Vol. 13 Issue 1, p1-10, 10p

Record details

Drug Therapies for Chronic Cholestatic Liver Diseases.

• Authors : Wagner, Martin; Fickert, Peter

Subjects: BILE duct diseases; BIOMARKERS; CHOLESTASIS

• Source: Annual Review of Pharmacology & Toxicology; Jan2020, Vol. 60, p503-527, 22p

Record details

Systematic review: recurrent autoimmune liver diseases after liver transplantation.

• Authors : Montano‐Loza, A. J.; Bhanji, R. A.; Wasilenko, S.

Subjects: AUTOIMMUNE diseases; LIVER diseases; LIVER transplantation

• Source: Alimentary Pharmacology & Therapeutics. Feb2017, Vol. 45 Issue 4, p485-500. 16p.

Record details

Adult idiopathic cholestasis: a condition more common in the Canadian Inuit?

• Authors : Minuk, Gerald Y.; Pollock, Galia; Uhanova, Julia

Subjects: CHOLESTASIS; CHOLANGITIS; INUIT

• Source: International Journal of Circumpolar Health; 2017, Vol. 76 Issue 1, p1-N.PAG, 6p

Record details

Cytokine-induced acceleration of cholangitis, polyglandular pathology and autoantibodies: an important mechanism in development of PBC?

• Authors : Joplin, Ruth¹

Subjects: *CIRRHOSIS of the liver; *ANTIGENS; *AUTOANTIBODIES

• Source: Liver International. Jun2005, Vol. 25 Issue 3, p469-471. 3p.

Record details

It is time to change primary biliary cirrhosis (PBC): New nomenclature from 'cirrhosis' to 'cholangitis', and upcoming treatment based on unveiling pathology.

• Authors : Shimoda, Shinji; Tanaka, Atsushi

Subjects: BILIARY liver cirrhosis; CIRRHOSIS of the liver; CHOLANGITIS

• Source: Hepatology Research; Mar2016, Vol. 46 Issue 5, p407-415, 9p

Record details